IGC Pharma, Inc. (IGC)
NYSEAMERICAN: IGC · Real-Time Price · USD
0.350
+0.017 (4.98%)
Nov 21, 2024, 3:12 PM EST - Market open

IGC Pharma Ratios and Metrics

Millions USD. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Nov '24 Mar '24 Mar '23 Mar '22 Mar '21 Mar '20 2019 - 2015
Market Capitalization
272618488119
Upgrade
Market Cap Growth
41.06%46.64%-62.80%-40.34%321.48%-76.60%
Upgrade
Enterprise Value
25251437794
Upgrade
Last Close Price
0.330.400.340.951.790.49
Upgrade
Forward PE
-4.354.354.354.354.35
Upgrade
PS Ratio
19.5019.6519.78122.0390.434.73
Upgrade
PB Ratio
3.463.611.212.032.480.73
Upgrade
P/TBV Ratio
5.794.631.312.112.510.73
Upgrade
PEG Ratio
2.262.262.262.262.262.26
Upgrade
EV/Sales Ratio
20.7718.9014.8293.5788.341.01
Upgrade
Debt / Equity Ratio
0.020.050.030.030.030.02
Upgrade
Asset Turnover
0.090.100.040.010.030.13
Upgrade
Inventory Turnover
0.250.290.150.040.141.76
Upgrade
Quick Ratio
0.570.551.834.536.276.41
Upgrade
Current Ratio
1.521.583.416.199.939.12
Upgrade
Return on Equity (ROE)
-117.06%-116.95%-59.30%-52.97%-29.70%-24.34%
Upgrade
Return on Assets (ROA)
-43.37%-45.23%-32.86%-29.10%-16.82%-13.52%
Upgrade
Return on Capital (ROIC)
-52.83%-53.12%-36.25%-31.25%-17.87%-14.12%
Upgrade
Earnings Yield
-48.69%-49.20%-63.85%-31.00%-10.85%-37.97%
Upgrade
FCF Yield
-19.41%-20.20%-40.83%-15.89%-15.11%-67.82%
Upgrade
Buyback Yield / Dilution
-29.63%-11.91%-5.17%-19.13%-6.26%-11.57%
Upgrade
Total Shareholder Return
-29.63%-11.91%-5.17%-19.13%-6.26%-11.57%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.